Subgroup analysis of OS according to tumor localization revealed a significantly worse OS of patients with aberrant p53 expression patterns especially in distally located tumors (p log rank = 0.010; HR, 2.19; 95% CI 1.19–4.03, Figure 2B). Here, TP53 is linked to neoplasm.